These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature. Simonart T; Hermans P; Schandene L; Van Vooren JP Br J Dermatol; 2000 Sep; 143(3):557-63. PubMed ID: 10971329 [TBL] [Abstract][Full Text] [Related]
30. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. Kaaya EE; Parravicini C; Ordonez C; Gendelman R; Berti E; Gallo RC; Biberfeld P J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):295-305. PubMed ID: 7552491 [TBL] [Abstract][Full Text] [Related]
31. Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors. Barillari G; Franzese O; Comandini A; Bonmassar E; Ensoli B Oncol Rep; 2010 Jul; 24(1):219-23. PubMed ID: 20514465 [TBL] [Abstract][Full Text] [Related]
32. Desferrioxamine enhances AIDS-associated Kaposi's sarcoma tumor development in a xenograft model. Simonart T; Boelaert JR; Andrei G; van den Oord JJ; Degraef C; Hermans P; Noel JC; Van Vooren JP; Heenen M; De Clercq E; Snoeck R Int J Cancer; 2002 Jul; 100(2):140-3. PubMed ID: 12115561 [TBL] [Abstract][Full Text] [Related]
33. Gene expression profile of AIDS-related Kaposi's sarcoma. Cornelissen M; van der Kuyl AC; van den Burg R; Zorgdrager F; van Noesel CJ; Goudsmit J BMC Cancer; 2003 Mar; 3():7. PubMed ID: 12697073 [TBL] [Abstract][Full Text] [Related]
34. Correlation between AIDS-related Kaposi sarcoma histological grade and in vitro behavior: reduced exogenous growth factor requirements for isolates from high grade lesions. Bailer RT; Lazo A; Ng-Bautista CL; Hout BL; Ness GM; Hegtvedt AK; Lantry LE; Blakeslee JR; Stephens RE; Brierley GP Lymphology; 1995 Sep; 28(3):126-37. PubMed ID: 7475261 [TBL] [Abstract][Full Text] [Related]
35. Expression of interleukin-6 receptors and NF-kappa B in AIDS-related Kaposi sarcoma cell strains. Bailer RT; Ng-Bautista CL; Ness GM; Mallery SR Lymphology; 1997 Jun; 30(2):63-76. PubMed ID: 9215976 [TBL] [Abstract][Full Text] [Related]
36. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646 [TBL] [Abstract][Full Text] [Related]
37. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928 [TBL] [Abstract][Full Text] [Related]
38. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis. Mori S; Murakami-Mori K; Jewett A; Nakamura S; Bonavida B Cancer Res; 1996 Apr; 56(8):1874-9. PubMed ID: 8620507 [TBL] [Abstract][Full Text] [Related]
39. Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy. Leigh BR; Burke PA; Hong AM; O'Donnell RT; Howell LP; Miers LA; DeNardo GL; DeNardo SJ Cancer Biother Radiopharm; 1999 Apr; 14(2):113-9. PubMed ID: 10850294 [TBL] [Abstract][Full Text] [Related]
40. Involvement of vascular endothelial growth factor in Kaposi's sarcoma associated with acquired immunodeficiency syndrome. Sakurada S; Kato T; Mashiba K; Mori S; Okamoto T Jpn J Cancer Res; 1996 Nov; 87(11):1143-52. PubMed ID: 9045943 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]